Pill with imprint H U 6 is White, Round and has been identified as Allopurinol 300 mg. It is supplied by Camber Pharmaceuticals, Inc. Allopurinol is used in the treatment of Gout; Calcium Oxalate Calculi with Hyperuricosuria; Hyperuricemia Secondary to Chemotherapy and belongs to the drug classes antigout agents, antihyperuricemic agents.

Pill Identifier results for "h u 6". Search by imprint, shape, color or drug name.

Includes images and details for pill imprint H U 6 including shape, color, size, NDC codes and manufacturers.

Includes images and details for pill imprint U6 including shape, color, size, NDC codes and manufacturers.

Use WebMD’s Pill Identifier to find and identify any over-the-counter or prescription drug, pill, or medication by color, shape, or imprint and easily compare pictures of multiple drugs.

Pill with imprint U6 is White, Round and has been identified as Adthyza 60 mg (38 mcg of T4 9 mcg of T3). It is supplied by Azurity Pharmaceuticals, Inc. Adthyza is used in the treatment of Underactive Thyroid and belongs to the drug class thyroid drugs.

NDC#31722-252-01 UPC Code331722252010 ImprintU5 | H Download Label Download HDA Sheet 100 mg / 500 count

2025年1月24日 · Know the medication and dose you should have received, and understand your medical conditions. The RxList Pill Identifier Tool will help you identify prescription, over-the-counter (OTC), generic, and brand name drugs by pill color, size, shape, and drug imprint. Match your drug imprint (Pill ID) to the pictures and quickly identify your ...

2011年8月13日 · I found a small white pill nothing on one side & underlined H on the other ## Where was it found? This is kind of a vague imprint, which leads me to suspect that it is probably something available over the counter. I haven't found a …

2023年1月3日 · Cyclobenzaprine hydrochloride tablets, USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal ... Hypersensitivity to any component of this product. Concomitant use of monoamine oxidase (MAO) inhibitors or within 14 days after their discontinuation.